The Implantable Port Market is segmented by application, with chemotherapy holding the largest share. According to the MRFR report, implantable ports are widely used for the administration of chemotherapy drugs to cancer patients. Chemotherapy often requires frequent intravenous infusions over an extended period, and implantable ports provide a reliable and convenient access point. The port reduces the need for repeated needle sticks, which can be painful and damaging to peripheral veins. The dominance of this segment is driven by the high global incidence of cancer and the widespread use of chemotherapy as a primary treatment modality.

While chemotherapy leads, antibiotic therapy and total parenteral nutrition (TPN) are the fastest-growing segments. Antibiotic therapy is used to treat serious infections that require long-term intravenous administration of antibiotics. Implantable ports are particularly useful for patients with conditions such as osteomyelitis, endocarditis, and cystic fibrosis, who may require weeks or months of intravenous antibiotics. The growing prevalence of antibiotic-resistant infections and the need for long-term treatment are driving demand.

Total parenteral nutrition (TPN) is a life-sustaining therapy that provides complete nutrition intravenously to patients who cannot eat or absorb nutrients through their digestive tract. TPN is used for patients with conditions such as short bowel syndrome, Crohn's disease, and cancer. Implantable ports provide a reliable and long-term access point for TPN administration. The increasing prevalence of these conditions is driving demand for implantable ports in the TPN segment.

Other applications include blood transfusion and the administration of other medications, such as pain management drugs and antiemetics.

The growth of the chemotherapy segment is driven by the high incidence of cancer and the widespread use of chemotherapy. The growth of the antibiotic therapy and TPN segments is driven by the increasing prevalence of chronic infections and gastrointestinal disorders. As the burden of chronic diseases continues to rise, the demand for implantable ports across all applications is expected to increase.